BELITE BIO, INC·4

May 7, 4:15 PM ET

MATA NATHAN L. 4

4 · BELITE BIO, INC · Filed May 7, 2026

Research Summary

AI-generated summary of this filing

Updated

Belite Bio (BLTE) CSO Nathan L. Mata Sells Shares

What Happened
Nathan L. Mata, Chief Scientific Officer of Belite Bio (BLTE), sold a total of 1,000 American Depositary Shares (ADS) in multiple open-market disposals on May 6, 2026, for aggregate proceeds of approximately $153,840. The sales were executed in six tranches: 8 ADS @ $151.57 ($1,213); 424 ADS @ $152.67 ($64,733); 128 ADS @ $153.42 ($19,638); 240 ADS @ $154.41 ($37,059); 100 ADS @ $155.97 ($15,597); and 100 ADS @ $156.00 ($15,600). Each ADS represents one ordinary share of the issuer.

Key Details

  • Transaction date: May 6, 2026; Form 4 filed May 7, 2026 (timely).
  • Total shares sold: 1,000 ADS; total proceeds ≈ $153,840.
  • Price range across sales: approximately $151.17 to $156.00 (weighted averages reported for groups).
  • Reported under sales code S (sale/disposition).
  • Footnotes: trades were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025; filer offers to provide per-price breakdowns on request (per footnotes F3–F6).
  • Shares owned after the transactions: not disclosed in the provided filing.

Context

  • These were scheduled sales under a 10b5-1 plan, which means the trades were prearranged and executed according to that plan rather than ad hoc decisions tied to public announcements.
  • Sales are generally treated as routine insider disposals; purchases tend to be more indicative of a direct bullish signal.
  • No options exercise, gift, or tax-withholding event is reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-05-06
MATA NATHAN L.
Chief Scientific Officer
Transactions
  • Sale

    American depositary share

    [F1][F2][F3]
    2026-05-06$151.57/sh8$1,2131,658 total
  • Sale

    American depositary share

    [F1][F2][F4]
    2026-05-06$152.67/sh424$64,7331,234 total
  • Sale

    American depositary share

    [F1][F2][F5]
    2026-05-06$153.42/sh128$19,6381,106 total
  • Sale

    American depositary share

    [F1][F2][F6]
    2026-05-06$154.41/sh240$37,059866 total
  • Sale

    American depositary share

    [F1][F2]
    2026-05-06$155.97/sh100$15,597766 total
  • Sale

    American depositary share

    [F1][F2]
    2026-05-06$156.00/sh100$15,600666 total
Footnotes (6)
  • [F1]Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025.
  • [F3]Represents the weighted average price of shares sold at prices that ranged from $151.17 to $151.97. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F4]Represents the weighted average price of shares sold at prices that ranged from $152.25 to $152.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F5]Represents the weighted average price of shares sold at prices that ranged from $153 to $153.98. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
  • [F6]Represents the weighted average price of shares sold at prices that ranged from $154.02 to $154.64. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
Signature
/s/ Nathan L. Mata|2026-05-07

Documents

1 file
  • 4
    ownership.xmlPrimary

    4